These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31257164)

  • 1. Prognostic value of neutrophil-to-lymphocyte ratio in older patients with head and neck cancer.
    Ku JY; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    J Geriatr Oncol; 2020 Apr; 11(3):417-422. PubMed ID: 31257164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 3. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.
    Yanni A; Buset T; Bouland C; Loeb I; Lechien JR; Rodriguez A; Journe F; Saussez S; Dequanter D
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4103-4111. PubMed ID: 35099595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
    Head Neck; 2018 Mar; 40(3):647-655. PubMed ID: 29076207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
    Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
    Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis.
    Mascarella MA; Mannard E; Silva SD; Zeitouni A
    Head Neck; 2018 May; 40(5):1091-1100. PubMed ID: 29356179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck.
    Ferrandino RM; Roof S; Garneau J; Haidar Y; Bates SE; Park YA; Bauml JM; Genden EM; Miles B; Sigel K
    Head Neck; 2020 Oct; 42(10):2830-2840. PubMed ID: 32592262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Yang L; Huang Y; Zhou L; Dai Y; Hu G
    Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of posttreatment neutrophil-lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Kim DY; Kim IS; Park SG; Kim H; Choi YJ; Seol YM
    Auris Nasus Larynx; 2017 Apr; 44(2):199-204. PubMed ID: 27269133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
    Cho JK; Kim MW; Choi IS; Moon UY; Kim MJ; Sohn I; Kim S; Jeong HS
    BMC Cancer; 2018 Oct; 18(1):969. PubMed ID: 30309318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.
    Charles KA; Harris BD; Haddad CR; Clarke SJ; Guminski A; Stevens M; Dodds T; Gill AJ; Back M; Veivers D; Eade T
    BMC Cancer; 2016 Feb; 16():124. PubMed ID: 26892430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
    Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
    Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
    Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
    Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios as Prognostic Markers of Survival in Patients with Head and Neck Tumours-Results of a Retrospective Multicentric Study.
    Szilasi Z; Jósa V; Zrubka Z; Mezei T; Vass T; Merkel K; Helfferich F; Baranyai Z
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32155982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated neutrophil-lymphocyte ratio predicts mortality following elective endovascular aneurysm repair.
    King AH; Schmaier AH; Harth KC; Kumins NH; Wong VL; Zidar DA; Kashyap VS; Cho JS
    J Vasc Surg; 2020 Jul; 72(1):129-137. PubMed ID: 32037083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
    Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
    BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer.
    Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Ann Oncol; 2014 Jun; 25(6):1208-14. PubMed ID: 24669018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.